n.rowntree
TL3 Regular · Bucharest, RO
Wiki editor. Small, frequent, well-annotated edits.
Joined 15 August 2024 · last posted 5d · groups: wiki-editors
132 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #57 · Access › Insurance & coverage · 22 Jul 2026 · 1 like On post #53 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #143 · Sourcing › Logistics · 22 Jul 2026 · 0 likes This follows post #140 rather than contradicting it. Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent,…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #48 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 23 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Insurance and replacement policies, compared Replied, post #91 · Sourcing › Logistics · 15 Jul 2026 · 10 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #13 · Compounds › Tirzepatide · 14 Jul 2026 · 2 likes Coming back to post #11, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #6 · Practice › Administration · 11 Jul 2026 · 24 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #42 · Research Methods › Statistics · 11 Jul 2026 · 11 likes Coming back to post #40, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
What a certificate commits its issuer to Replied, post #11 · Analytics › COA interpretation · 10 Jul 2026 · 3 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Prescription portability between countries Replied, post #87 · Access › International · 4 Jul 2026 · 0 likes I read post #85 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
What a certificate commits its issuer to — the long version Replied, post #20 · Analytics › COA interpretation · 3 Jul 2026 · 0 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Pages past their review date, listed — does this still hold? Replied, post #34 · Meta › Wiki maintenance · 2 Jul 2026 · 20 likes post #33 answers the question as asked. The question underneath it is different. Revision disputes: if you disagree with an edit a maintainer made, discussing it here…
-
The anatomy of a question that gets answered within an hour Replied, post #95 · Start Here › How to Ask · 30 Jun 2026 · 26 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #80 · Practice › Storage & stability · 28 Jun 2026 · 9 likes post #79 answers the question as asked. The question underneath it is different. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure…
-
What a reversed-phase purity number actually is Replied, post #9 · Analytics › HPLC & UHPLC · 28 Jun 2026 · 23 likes I read post #7 twice before replying, because I had assumed the opposite. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #36 · Practice › Side effects · 28 Jun 2026 · 0 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Tracking a shortage from primary sources rather than rumour Replied, post #70 · Access › Shortages · 26 Jun 2026 · 0 likes Picking up post #67: that is the part I would want checked first. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when…
-
Pooling trials with different estimands Replied, post #34 · Evidence › Meta-analyses · 19 Jun 2026 · 0 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
What I would want from a home test that does not exist yet Replied, post #14 · Analytics › Home & field testing · 19 Jun 2026 · 0 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #82 · Evidence › Preprints · 18 Jun 2026 · 27 likes On post #78 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #3 · Compounds › Retatrutide · 17 Jun 2026 · 0 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Pooling trials with different estimands Replied, post #23 · Evidence › Meta-analyses · 13 Jun 2026 · 20 likes Picking up post #20: that is the part I would want checked first. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a…
-
Reading a home test result without over-claiming Replied, post #78 · Analytics › Home & field testing · 13 Jun 2026 · 0 likes Coming back to post #76, because the follow-up matters more than the original answer. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #25 · Practice › Reconstitution · 9 Jun 2026 · 0 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #22 · Compounds › Tirzepatide · 7 Jun 2026 · 1 like SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #19 · Research Methods › N-of-1 designs · 22 May 2026 · 3 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
Transporting a vial for a weekend away — a second dataset Replied, post #47 · Practice › Storage & stability · 7 May 2026 · 5 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
The "under review" status pill and when a moderator applies it Replied, post #117 · Evidence › Preprints · 6 May 2026 · 26 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Request: show the solution author in the topic list — what changed since Replied, post #33 · Meta › Feature requests · 1 May 2026 · 32 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #3 · Analytics › HPLC & UHPLC · 17 Apr 2026 · 32 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
List price versus negotiated price versus what you pay Replied, post #110 · Access › Pricing · 17 Apr 2026 · 13 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #96 · Practice › Storage & stability · 10 Apr 2026 · 1 like Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Journal club: LEADER as the historical anchor Replied, post #58 · Evidence › Journal club · 10 Apr 2026 · 30 likes I read post #56 twice before replying, because I had assumed the opposite. Session format: read the paper before posting. The discussion is much better when everyone…
-
Spike-and-recover accuracy for a peptide assay Replied, post #47 · Analytics › Method validation · 8 Apr 2026 · 4 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #88 · Sourcing › Vendor reports · 31 Mar 2026 · 7 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #17 · Evidence › Journal club · 29 Mar 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #74 · Practice › Interactions · 25 Mar 2026 · 4 likes Picking up post #71: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
[2026 update] What a purity-only report leaves out Replied, post #65 · Sourcing › Independent verification · 24 Mar 2026 · 1 like Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Search filters: what is missing Replied, post #39 · Meta › Site feedback · 24 Mar 2026 · 11 likes Search and findability: if you searched for something and did not find it, report what you searched for and what you expected to find. That helps improve indexing and…
-
Grapefruit: why this class is not the class that cares Replied, post #70 · Practice › Interactions · 23 Mar 2026 · 12 likes post #69 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #3 · Clinical › Prescriber conversations · 22 Mar 2026 · 0 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Second pass at: Fasting versus non-fasting and which tests care Replied, post #19 · Clinical › Bloodwork · 15 Mar 2026 · 10 likes Worth separating two things that post #15 runs together. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening.…
-
Why oral semaglutide needs an absorption enhancer at all — one year on Replied, post #9 · Compounds › Oral incretins · 14 Mar 2026 · 13 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Cost per delivered dose, which is the number that matters Replied, post #56 · Access › Pricing · 11 Mar 2026 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #40 · Research Methods › N-of-1 designs · 7 Mar 2026 · 21 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
The lowest dose that does anything: is that a real question? Replied, post #61 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #110 · Clinical › Special populations · 25 Feb 2026 · 14 likes I read post #108 twice before replying, because I had assumed the opposite. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #15 · Research Methods › N-of-1 designs · 25 Feb 2026 · 2 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
Measurement error in a self-reported exposure Replied, post #7 · Evidence › Study critique · 21 Feb 2026 · 0 likes Picking up post #4: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #8 · Sourcing › Red flags · 20 Feb 2026 · 31 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
How to ask about something you suspect is a bad idea Replied, post #57 · Start Here › How to Ask · 20 Feb 2026 · 11 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #49 · Compounds › Tirzepatide · 20 Feb 2026 · 1 like Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #116 · Analytics › Mass spectrometry · 15 Feb 2026 · 5 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #40 · Outcomes › Progress reports · 12 Feb 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Run-in periods and the population they select Replied, post #64 · Evidence › Trials · 10 Feb 2026 · 4 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #24 · Regional › UK & Ireland · 29 Jan 2026 · 0 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #99 · Practice › Interactions · 28 Jan 2026 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #3 · Compounds › Other compounds · 16 Jan 2026 · 4 likes On the opening post — agreed on the reasoning, with one qualification. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #32 · Analytics › Impurities & related substances · 5 Jan 2026 · 1 like Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
What "verified" means on our vendor pages, stated narrowly Replied, post #31 · Sourcing › Vendor reports · 3 Jan 2026 · 5 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
The headache that turns out to be dehydration Replied, post #95 · Nutrition & Training › Hydration & electrolytes · 14 Dec 2025 · 14 likes post #94 is right about the mechanism and I think understates the practical bit. Exercise and electrolyte losses: sweating during exercise increases sodium and…
-
Liver enzymes drifting down and what that usually means Replied, post #36 · Clinical › Bloodwork · 13 Dec 2025 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #13 · Sourcing › Red flags · 12 Dec 2025 · 31 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #2 · Outcomes › Body composition · 11 Dec 2025 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Lean mass loss during rapid weight reduction: depends on protein intake, resistance…
-
Robustness: the parameters worth deliberately varying Replied, post #51 · Analytics › Method validation · 8 Dec 2025 · 5 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
What I would record differently if I started again — the long version Replied, post #17 · Outcomes › Progress reports · 21 Nov 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Angle of injection and whether 90 degrees is always right Replied, post #53 · Practice › Administration · 20 Nov 2025 · 12 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Documentation that materially improves an appeal's chances Replied, post #57 · Access › Insurance & coverage · 9 Nov 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
EMA product information as a primary source Replied, post #35 · Regional › European Union · 5 Nov 2025 · 2 likes Worth separating two things that post #31 runs together. Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The…
-
Revisiting: German, French and Dutch differences, compared Replied, post #94 · Regional › European Union · 30 Oct 2025 · 0 likes post #93 is right about the mechanism and I think understates the practical bit. Italy: AIFA controls reimbursement through a note system. Weight-management indications…
-
Specification in the result column: why that is a meaningful error Replied, post #65 · Analytics › COA interpretation · 29 Oct 2025 · 14 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A 40-week log with the measurement method stated Replied, post #82 · Outcomes › Progress reports · 27 Oct 2025 · 0 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
History of disordered eating and why it changes the conversation Replied, post #19 · Clinical › Special populations · 25 Oct 2025 · 1 like Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Amylin receptor signalling and satiety Replied, post #7 · Pharmacology › Receptor biology · 22 Oct 2025 · 24 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #80 · Analytics › Home & field testing · 17 Oct 2025 · 20 likes post #79 is right about the mechanism and I think understates the practical bit. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #80 · Practice › Storage & stability · 12 Oct 2025 · 4 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #85 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 0 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #60 · Practice › Dosing & titration · 24 Sep 2025 · 8 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Temperature loggers worth the money — the long version Replied, post #39 · Devices › Cold chain · 12 Sep 2025 · 7 likes I read post #37 twice before replying, because I had assumed the opposite. Shipment during summer or to hot climates: consider shipping to a cold-storage facility…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #80 · Practice › Side effects · 8 Sep 2025 · 4 likes Coming back to post #78, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #95 · Practice › Reconstitution · 28 Jul 2025 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #26 · Compounds › Secretagogues & GH axis · 18 Jul 2025 · 18 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
[2026 update] Reverting an edit that had no revision note Started this topic · Meta › Wiki maintenance · 16 Jul 2025 · 12 likes Reverting an edit that had no revision note — setting out what I have, and where I think it stops being reliable. Process question about how this site works. I have…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #31 · Practice › Dosing & titration · 15 Jul 2025 · 4 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
What this community means by "a source", in practical terms Replied, post #35 · Start Here › Welcome · 15 Jul 2025 · 10 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
A field-by-field walk through a certificate of analysis Replied, post #17 · Analytics › COA interpretation · 14 Jul 2025 · 0 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #67 · Sourcing › Independent verification · 21 Jun 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #64 · Nutrition & Training › Protein & intake · 11 Jun 2025 · 28 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #73 · Outcomes › Body composition · 21 May 2025 · 0 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #53 · Compounds › Retatrutide · 20 May 2025 · 11 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #37 · Outcomes › Body composition · 13 May 2025 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The C-cell question: rodent findings and their human context Replied, post #11 · Compounds › Semaglutide · 26 Apr 2025 · 1 like Coming back to post #9, because the follow-up matters more than the original answer. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
Follow-up: Documentation that appears only after payment Replied, post #14 · Sourcing › Red flags · 22 Apr 2025 · 19 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Coming back to: Cross-border purchase rules within the EU Replied, post #3 · Regional › European Union · 21 Apr 2025 · 2 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #22 · Clinical › Comorbidities · 19 Apr 2025 · 9 likes Picking up post #19: that is the part I would want checked first. Interactions between comorbidities: diabetes and kidney disease together change the risk calculation…
-
Reaching a dose and staying there for a year: a longitudinal note Replied, post #2 · Practice › Dosing & titration · 18 Apr 2025 · 19 likes the opening post is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather…
-
Retatrutide dose escalation in the published trials Replied, post #138 · Compounds › Retatrutide · 16 Apr 2025 · 15 likes I read post #136 twice before replying, because I had assumed the opposite. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range…
-
Follow-up: Requesting a page: what makes a good request Replied, post #22 · Documentation › Wiki requests · 16 Apr 2025 · 0 likes On post #18 — agreed on the reasoning, with one qualification. Correction requests: if you spot an error in a maintained page, note it here with the specific…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #53 · Compounds › Tirzepatide · 3 Apr 2025 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Foaming during reconstitution and whether it matters Replied, post #8 · Practice › Reconstitution · 2 Apr 2025 · 0 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Certificates issued by the seller versus by a laboratory Replied, post #22 · Analytics › COA interpretation · 29 Mar 2025 · 1 like Coming back to post #20, because the follow-up matters more than the original answer. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #6 · Compounds › Retatrutide · 19 Mar 2025 · 2 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Fibre intake when total intake falls, and the constipation link Replied, post #36 · Nutrition & Training › Protein & intake · 5 Mar 2025 · 8 likes Worth separating two things that post #32 runs together. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #14 · Meta › Wiki maintenance · 3 Mar 2025 · 1 like Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #20 · Compounds › Tirzepatide · 2 Mar 2025 · 19 likes I read post #18 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #27 · Pharmacology › Receptor biology · 1 Mar 2025 · 13 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #19 · Compounds › Repair & healing peptides · 1 Mar 2025 · 0 likes Worth separating two things that post #15 runs together. TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #16 · Clinical › Comorbidities · 17 Feb 2025 · 4 likes post #15 answers the question as asked. The question underneath it is different. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed…
-
Validating a method you did not develop — does this still hold? Replied, post #3 · Analytics › Method validation · 11 Feb 2025 · 9 likes I read the opening post twice before replying, because I had assumed the opposite. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
When "no data" is the complete and final answer Replied, post #82 · Compounds › Other compounds · 2 Feb 2025 · 32 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #43 · Compounds › Semaglutide · 29 Jan 2025 · 0 likes post #42 is right about the mechanism and I think understates the practical bit. The STEP programme populations were selected: enrollment criteria required baseline…
-
How compounding permissions changed when supply normalised Replied, post #12 · Sourcing › Regulatory · 25 Jan 2025 · 0 likes post #11 is right about the mechanism and I think understates the practical bit. Preclinical versus clinical: compounds with strong preclinical data can fail in…
-
What changed in 2026, by region Replied, post #45 · Access › International · 28 Dec 2024 · 29 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #96 · Compounds › Oral incretins · 28 Dec 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #131 · Clinical › Prescriber conversations · 25 Dec 2024 · 12 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
-
Ipamorelin selectivity claims and where they came from Replied, post #2 · Compounds › Secretagogues & GH axis · 20 Dec 2024 · 20 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #84 · Devices › Syringes & needles · 18 Dec 2024 · 9 likes This follows post #81 rather than contradicting it. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer).…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #62 · Evidence › Journal club · 16 Dec 2024 · 3 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #40 · Clinical › Special populations · 8 Dec 2024 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #118 · Analytics › COA interpretation · 15 Nov 2024 · 7 likes post #117 answers the question as asked. The question underneath it is different. Water content (residual moisture) matters: lyophilised peptide is not dry. A few…
-
Time to steady state after a dose increase Replied, post #72 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 0 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #58 · Devices › Syringes & needles · 31 Oct 2024 · 9 likes Worth separating two things that post #54 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #109 · Clinical › Comorbidities · 26 Oct 2024 · 1 like Worth separating two things that post #105 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #100 · Access › Shortages · 12 Oct 2024 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #67 · Evidence › Journal club · 8 Oct 2024 · 5 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #5 · Evidence › Journal club · 8 Oct 2024 · 31 likes Worth separating two things that the opening post runs together. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #35 · Sourcing › Independent verification · 4 Sep 2024 · 0 likes On post #31 — agreed on the reasoning, with one qualification. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #5 · Practice › Administration · 2 Sep 2024 · 11 likes Worth separating two things that the opening post runs together. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #23 · Evidence › Journal club · 22 Aug 2024 · 0 likes Picking up post #20: that is the part I would want checked first. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #64 · Compounds › Retatrutide · 20 Jul 2024 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #17 · Safety › Contraindications · 19 Jul 2024 · 2 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #31 · Practice › Interactions · 11 Jul 2024 · 8 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Cold packs, phase-change material, and what survives ten days Replied, post #51 · Sourcing › Logistics · 28 Jun 2024 · 17 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.